Novel insight from the first lung transplant of a COVID-19 patient
- PMID: 33131070
- DOI: 10.1111/eci.13443
Novel insight from the first lung transplant of a COVID-19 patient
Abstract
Background: To reveal detailed histopathological changes, virus distributions, immunologic properties and multi-omic features caused by SARS-CoV-2 in the explanted lungs from the world's first successful lung transplantation of a COVID-19 patient.
Materials and methods: A total of 36 samples were collected from the lungs. Histopathological features and virus distribution were observed by optical microscope and transmission electron microscope (TEM). Immune cells were detected by flow cytometry and immunohistochemistry. Transcriptome and proteome approaches were used to investigate main biological processes involved in COVID-19-associated pulmonary fibrosis.
Results: The histopathological changes of the lung tissues were characterized by extensive pulmonary interstitial fibrosis and haemorrhage. Viral particles were observed in the cytoplasm of macrophages. CD3+ CD4- T cells, neutrophils, NK cells, γ/δ T cells and monocytes, but not B cells, were abundant in the lungs. Higher levels of proinflammatory cytokines iNOS, IL-1β and IL-6 were in the area of mild fibrosis. Multi-omics analyses revealed a total of 126 out of 20,356 significant different transcription and 114 out of 8,493 protein expression in lung samples with mild and severe fibrosis, most of which were related to fibrosis and inflammation.
Conclusions: Our results provide novel insight that the significant neutrophil/ CD3+ CD4- T cell/ macrophage activation leads to cytokine storm and severe fibrosis in the lungs of COVID-19 patient and may contribute to a better understanding of COVID-19 pathogenesis.
Keywords: COVID-19; SARS-CoV-2; inflammation; lung transplantation; pathology.
© 2020 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
Similar articles
-
Emergency Lung Transplantation after COVID-19: Immunopathological Insights on Two Affected Patients.Cells. 2021 Mar 10;10(3):611. doi: 10.3390/cells10030611. Cells. 2021. PMID: 33801959 Free PMC article.
-
COVID-19 Lung Pathogenesis in SARS-CoV-2 Autopsy Cases.Front Immunol. 2021 Oct 4;12:735922. doi: 10.3389/fimmu.2021.735922. eCollection 2021. Front Immunol. 2021. PMID: 34671353 Free PMC article.
-
Lung transplantation for patients with severe COVID-19.Sci Transl Med. 2020 Dec 16;12(574):eabe4282. doi: 10.1126/scitranslmed.abe4282. Epub 2020 Nov 30. Sci Transl Med. 2020. PMID: 33257409 Free PMC article.
-
Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients.Biomolecules. 2022 Dec 10;12(12):1845. doi: 10.3390/biom12121845. Biomolecules. 2022. PMID: 36551272 Free PMC article. Review.
-
Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19.J Med Virol. 2021 Mar;93(3):1378-1386. doi: 10.1002/jmv.26634. Epub 2020 Nov 1. J Med Virol. 2021. PMID: 33107641 Review.
Cited by
-
Dual inhibition of CB1 receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID-19.Br J Pharmacol. 2022 May;179(10):2121-2127. doi: 10.1111/bph.15461. Epub 2021 Apr 17. Br J Pharmacol. 2022. PMID: 33769552 Free PMC article.
-
How to Train Your Dragon: Harnessing Gamma Delta T Cells Antiviral Functions and Trained Immunity in a Pandemic Era.Front Immunol. 2021 Mar 29;12:666983. doi: 10.3389/fimmu.2021.666983. eCollection 2021. Front Immunol. 2021. PMID: 33854516 Free PMC article. Review.
-
Multiomics integration-based molecular characterizations of COVID-19.Brief Bioinform. 2022 Jan 17;23(1):bbab485. doi: 10.1093/bib/bbab485. Brief Bioinform. 2022. PMID: 34864875 Free PMC article. Review.
-
[Pericarditis is inflammation of the pericardium, which rheumatologists should know].Z Rheumatol. 2021 Feb;80(1):54-64. doi: 10.1007/s00393-020-00925-w. Epub 2020 Nov 20. Z Rheumatol. 2021. PMID: 33216192 Free PMC article. Review. German.
-
Application of Place-Based Methods to Lung Transplant Medicine.Int J Environ Res Public Health. 2022 Jun 15;19(12):7355. doi: 10.3390/ijerph19127355. Int J Environ Res Public Health. 2022. PMID: 35742599 Free PMC article.
References
REFERENCES
-
- Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733.
-
- Liu Y, Mao B, Liang S, et al. Association between ages and clinical characteristics and outcomes of coronavirus disease 2019. Eur Respir J. 2020;55(5):2001112.
-
- Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708-1720.
-
- Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061.
-
- Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-481.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous